Tags : (pegloprastide)

Regulatory

Avelas’ AVB-620 (pegloprastide) Receives the US FDA’s Breakthrough Therapy Designation

Shots: The US FDA has granted BTD to pegloprastide (AVB-620) for the intraoperative detection and visualization of positive margins during breast cancer surgery Earlier, the company reported results of P-II/III study that demonstrated the use of pegloprastide during surgery correctly identified cancer in ~ 75% of patients who would have otherwise been candidates for a […]Read More